Gemzar and Thrombocytosis - a phase IV clinical study of FDA data

Summary:

Thrombocytosis is reported as a side effect among people who take Gemzar (gemcitabine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cisplatin, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Thrombocytosis when taking Gemzar. It is created by eHealthMe based on reports of 20,184 people who have side effects when taking Gemzar from the FDA, and is updated regularly.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

What is Thrombocytosis?

Thrombocytosis is found to be associated with 536 drugs and 828 conditions by eHealthMe. Check the latest studies of Thrombocytosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

20,184 people reported to have side effects when taking Gemzar.
Among them, 46 people (0.23%) have Thrombocytosis.

Among these 46 people:

How long have people been on Gemzar when they have Thrombocytosis? *

What is the gender of people who have Thrombocytosis when taking Gemzar? *

female: 52.5 %
male: 47.5 %

What is the age of people who have Thrombocytosis when taking Gemzar? *

What are other drugs people take besides Gemzar? *

What are other side effects people have besides Thrombocytosis? *

Leukocytosis (increased white blood cells): 16 people, 34.78%
Anaemia (lack of blood): 15 people, 32.61%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 14 people, 30.43%
Neck Pain: 13 people, 28.26%
Fever: 13 people, 28.26%
Injury: 12 people, 26.09%
Exostosis (formation of new bone on the surface of a bone): 12 people, 26.09%
Intervertebral Disc Degeneration (spinal disc degeneration): 12 people, 26.09%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 12 people, 26.09%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 12 people, 26.09%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 6.52%
Adenocarcinoma Pancreas (cancer of pancreas): 2 people, 4.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.35%
Neoplasm Malignant (cancer tumour): 2 people, 4.35%
Metastatic Neoplasm (spreadable cancer tumour): 2 people, 4.35%
Metastases To Peritoneum (cancer spreads to peritoneum): 2 people, 4.35%
Bladder Transitional Cell Carcinoma (types of bladder cancer): 2 people, 4.35%
Diabetes: 2 people, 4.35%
Pain: 2 people, 4.35%
Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue): 2 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Gemzar and have Thrombocytosis?

- Check whether Thrombocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemzar:

Gemzar (20,315 reports)

Thrombocytosis treatments and more:

Thrombocytosis (5,580 reports)

Browse all side effects of Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytosis:

Thrombocytosis (536 drugs)

Browse all the conditions that are associated with Thrombocytosis:

Thrombocytosis (828 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemzar) and Gemzar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.